Sign up to save your podcasts
Or
Share Episode 13: Graeme Bradshaw on Non-Alcoholic Fatty Liver Disease and NASH
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 13: Graeme Bradshaw on Non-Alcoholic Fatty Liver Disease and NASH
For today’s discussion, we move on from detoxification and explore the two most prevalent liver diseases, non-alcoholic fatty liver disease and it’s more aggressive sibling, NASH or Non-Alcoholic—Steato-Hepatitis.
Just fatty liver on it’s own is estimated to have a worldwide prevalence of 25%. In Hong Kong this number is lower at around 14% but the progression towards fibrosis and NASH is increasing quickly, with some case showing signs of NASH in just three years.
View all episodes
By INL AsiaFor today’s discussion, we move on from detoxification and explore the two most prevalent liver diseases, non-alcoholic fatty liver disease and it’s more aggressive sibling, NASH or Non-Alcoholic—Steato-Hepatitis.
Just fatty liver on it’s own is estimated to have a worldwide prevalence of 25%. In Hong Kong this number is lower at around 14% but the progression towards fibrosis and NASH is increasing quickly, with some case showing signs of NASH in just three years.